ProCE Banner Activity

The Complexities of NA Discontinuation in Patients With Chronic HBV Infection

Clinical Thought
What are the pros and cons of discontinuing oral therapy with nucleos(t)ide analogues in patients with chronic HBV infection? Here’s my take.

Released: July 10, 2020

Expiration: July 09, 2021

No longer available for credit.

Share

Faculty

Pietro Lampertico

Pietro Lampertico, MD, PhD

Professor of Gastroenterology
Director, Division of Gastroenterology and Hepatology
IRCCS Ca Granda Policlinico Hospital
University of Milan
Milan, Italy

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Gilead

Faculty Disclosure

Primary Author

Pietro Lampertico, MD, PhD

Professor of Gastroenterology
Director, Division of Gastroenterology and Hepatology
IRCCS Ca Granda Policlinico Hospital
University of Milan
Milan, Italy

Pietro Lampertico, MD, PhD, has disclosed that he has received consulting fees from AbbVie, Eiger, Gilead Sciences, Janssen, MSD, MYR, and Roche.